Vaccine Insights Webinars

VACCINE INSIGHTS

Controlled human infection models in vaccine development: what’s new in 2025?

Controlled human infection models in vaccine development: what’s new in 2025?

M B. Laurens, A P. Durbin, M Cavaleri et al

Exploring mRNA quality assessment using electrophoretic separation methods

Exploring mRNA quality assessment using electrophoretic separation methods

Chateen Krueger

Achieving high-quality, efficient mRNA synthesis for streamlined and cost-effective manufacturing

Achieving high-quality, efficient mRNA synthesis for streamlined and cost-effective manufacturing

Helge Zieler, Khaled Yamout

Sharpen up your RNA and LNP quant with Stunner

Sharpen up your RNA and LNP quant with Stunner

Faster, smaller, smarter: intelligent manufacturing of mRNA through the power of process analytical technologies

Faster, smaller, smarter: intelligent manufacturing of mRNA through the power of process analytical technologies

Aaron Cowley, Edita Botonjic-Sehic

11 December 2024

Quality by design in mRNA manufacturing: at-line monitoring coupled with DOE for higher IVT yield and efficiency of purification

Quality by design in mRNA manufacturing: at-line monitoring coupled with DOE for higher IVT yield and efficiency of purification

03 December 2024

mRNA characterization - from 5’ cap to poly (A): what IPRP-LC–MS can tell you

mRNA characterization - from 5’ cap to poly (A): what IPRP-LC–MS can tell you

Roxana Eggleston

06 November 2024

Elevate LNP optimization with Sunshine and Stunner

Elevate LNP optimization with Sunshine and Stunner

17 October 2024

Advancing LNP characterization for drug delivery: NeoVac

Advancing LNP characterization for drug delivery: NeoVac

Tristan Kovačič, Blaz Bakalar, Dan Peer

08 October 2024

Enhancing mRNA production with advanced analytics: WACKER Biotech

Enhancing mRNA production with advanced analytics: WACKER Biotech

Michael Daume, Blaz Bakalar

08 October 2024

1
2
3
4
5
>
>>